FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $367,000 | -38.4% | 110,343 | -43.7% | 0.01% | -30.8% |
| Q3 2019 | $596,000 | +70.8% | 196,160 | +33.7% | 0.01% | +44.4% |
| Q2 2019 | $349,000 | -20.7% | 146,745 | +25.0% | 0.01% | -30.8% |
| Q1 2019 | $440,000 | +29.8% | 117,367 | +24.4% | 0.01% | -7.1% |
| Q4 2018 | $339,000 | -40.7% | 94,378 | -5.5% | 0.01% | -17.6% |
| Q3 2018 | $572,000 | +7.5% | 99,901 | -6.0% | 0.02% | -10.5% |
| Q2 2018 | $532,000 | +14.9% | 106,243 | +17.7% | 0.02% | -17.4% |
| Q1 2018 | $463,000 | +97.0% | 90,263 | +130.5% | 0.02% | +21.1% |
| Q4 2017 | $235,000 | – | 39,160 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |